Journals / European Journal of Rheumatology / 2019 / Cilt: 6 - Sayı: 4

The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis

Pages
184–192
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, rheumatologists should encourage pa-tients with AS to quit smoking.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study was to determine whether smoking was associated with the cu-mulative radiographic spinal damage and radiographic progression in patients with ankylosing spon-dylitis (AS).
📊
Key Findings & Data:Thus, we conducted a systematic review and meta-analysis of the available studies to date.Methods: An electronic search was conducted from inception to June 21, 2016, in EMBASE, the MED-LINE/PubMed Cochrane Central Register of Controlled Trials databases.
💡
Conclusion & Impact:Therefore, rheumatologists should encourage pa-tients with AS to quit smoking.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study was to determine whether smoking was associated with the cu-mulative radiographic spinal damage and radiographic progression in patients with ankylosing spon-dylitis (AS). Thus, we conducted a systematic review and meta-analysis of the available studies to date.Methods: An electronic search was conducted from inception to June 21, 2016, in EMBASE, the MED-LINE/PubMed Cochrane Central Register of Controlled Trials databases. Cross-sectional and longitu-dinal cohort studies investigating the association between smoking and cumulative spinal structural damage or radiographic progression were included. The outcome of interest was the presence of syndesmophytes in cross-sectional studies and radiographic progression in longitudinal studies. The quality assessment was done using the Agency for Healthcare Research and Quality checklist. The authors of potentially relevant studies were contacted regarding the unpublished data. Data from eligible cross-sectional studies were extracted and arranged in a 2x2 table. The odds ratios (ORs) and 95% confidence intervals (CIs) for the dichotomous outcome of interest were computed.Results: The combined data of eight eligible cross-sectional studies for the assessment of associa-tion between smoking and cumulative spinal structural damage suggested a significant association (OR, 2.02; 95% CI, 1.51–2.70). No significant heterogeneity was detected between studies (I2=23.0%, p=0.25). The heterogeneity of the longitudinal study data did not permit us to undertake a meta-anal-ysis. Hence, a qualitative review was performed.Conclusion: The results of our meta-analysis show that smoking is associated with increased cumula-tive spinal structural damage in patients with AS. Therefore, rheumatologists should encourage pa-tients with AS to quit smoking.

🔖

Cite This Article

GÜCENMEZ, S., GERCİK, Ö., SOLMAZ, D., AKAR, S., Keskin-ARSLAN, E., KAPLAN, Y. C. (2022). The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis. European Journal of Rheumatology, Cilt: 6 - Sayı: 4, 184–192. https://ajindex.com/articles/511603

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Lories RJ, Haroon N. Bone formation in axial spondyloarthritis. Best Pract Res Clin Rheumatol 2014
  2. [CrossRef] 2. Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radio-graphic progression in early axial spondylarthritis. Arthritis Rheum 2012
  3. [CrossRef] 3. Machado P, Landewé R, Braun J, Hermann KGA, Baker D, Van Der Heijde D. Both structural dam-age and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 2010
  4. [CrossRef] 4. Healey EL, Haywood KL, Jordan KP, Garratt A, Packham JC. Impact of ankylosing spondylitis on work in patients across the UK. Scand J Rheu-matol 2011
  5. [CrossRef] 5. Joo Y Bin, Bang S-Y, Kim T-H, Shim S-C, Lee S, Joo K Bin, et al. Bone Morphogenetic Protein 6 Poly-morphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis. PLoS One 2014
  6. e104966. [CrossRef] 6. Kwon SR, Lim MJ, Suh CH, Park SG, Hong YS, Yoon BY, et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor ther-apy. Rheumatol Int 2012
  7. [CrossRef] 7. Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, et al. Altered skeletal ex-pression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009
  8. [CrossRef] 8. olmaz D, Uslu S, Kozaci D, Karaca N, Bulbul H, Tar-han EF, et al. Evaluation of periostin and factors associated with new bone formation in anky-losing spondylitis: Periostin may be associated with the Wnt pathway. Int J Rheum Dis 2018
  9. [CrossRef] 9. Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 2014
  10. [CrossRef] 10. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: Smok-ing may trigger HLA-DR (shared epitope)-re-stricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006
  11. [CrossRef] 11. Chung HY, Machado P, van der Heijde D, D’Agos-tino MA, Dougados M. Smokers in ea